NO955361L - Organiske aerogeler - Google Patents

Organiske aerogeler

Info

Publication number
NO955361L
NO955361L NO955361A NO955361A NO955361L NO 955361 L NO955361 L NO 955361L NO 955361 A NO955361 A NO 955361A NO 955361 A NO955361 A NO 955361A NO 955361 L NO955361 L NO 955361L
Authority
NO
Norway
Prior art keywords
aerogels
organic aerogels
diagnostic
agents
pyrolyzed
Prior art date
Application number
NO955361A
Other languages
English (en)
Other versions
NO955361D0 (no
Inventor
Arne Berg
Michael William Droege
Jere Douglas Fellmann
Jo Klaveness
Paal Rongved
Original Assignee
Nycomed Imaging As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nycomed Imaging As filed Critical Nycomed Imaging As
Publication of NO955361D0 publication Critical patent/NO955361D0/no
Publication of NO955361L publication Critical patent/NO955361L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/56—Porous materials, e.g. foams or sponges
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/18—Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/52—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/58—Materials at least partially resorbable by the body

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Fysiologisk akseptable organiske aerogeler, inkludert pyrolyserte aerogeler, for bruk i medisin, for eksempel som diagnostiske midler, kunstig vev, organer og organkomponenter etc. og spesielt i systemer for legemiddelfrigivelse. Bruk av biodegraderbare organiske aerogeler, som i seg selv er nye materialer, er foretrukne materialer f.eks. diagnostiske og terapeutiske midler for ; parenteral administrering.
NO955361A 1993-06-30 1995-12-29 Organiske aerogeler NO955361L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB939313501A GB9313501D0 (en) 1993-06-30 1993-06-30 Improvements in or relating to polymer materials
PCT/GB1994/001421 WO1995001165A1 (en) 1993-06-30 1994-06-30 Medical use of organic aerogels and biodegradable organic aerogels

Publications (2)

Publication Number Publication Date
NO955361D0 NO955361D0 (no) 1995-12-29
NO955361L true NO955361L (no) 1996-02-20

Family

ID=10738047

Family Applications (1)

Application Number Title Priority Date Filing Date
NO955361A NO955361L (no) 1993-06-30 1995-12-29 Organiske aerogeler

Country Status (7)

Country Link
EP (1) EP0707474B1 (no)
JP (1) JPH09500114A (no)
AU (1) AU7006794A (no)
DE (1) DE69425573T2 (no)
GB (1) GB9313501D0 (no)
NO (1) NO955361L (no)
WO (1) WO1995001165A1 (no)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19506141A1 (de) * 1995-02-22 1996-08-29 Hoechst Ag Verwendung von Aerogelen in der Pharmazie, in der Kosmetik und im Pflanzenschutz
US7005181B2 (en) 2000-04-06 2006-02-28 American Aerogel Corporation Organic, open cell foam materials, their carbonized derivatives, and methods for producing same
CA2429773A1 (en) * 2000-12-22 2002-07-04 Aspen Aerogels, Inc. Aerogel powder comprising therapeutic agents
JP2003002972A (ja) * 2001-06-25 2003-01-08 Mitsui Chemicals Inc 高純度ポリアミノ酸誘導体の製造方法
DE10214226B4 (de) * 2001-10-11 2009-07-16 Arlt, Wolfgang Wirkstoffträger, Verfahren zu dessen Herstellung und Verwendung
US7065411B2 (en) 2003-04-23 2006-06-20 Medtronic, Inc. Electrical medical leads employing conductive aerogel
US7723262B2 (en) 2005-11-21 2010-05-25 Energ2, Llc Activated carbon cryogels and related methods
US7835136B2 (en) 2006-11-15 2010-11-16 Energ2, Inc. Electric double layer capacitance device
JP5581056B2 (ja) 2006-12-15 2014-08-27 ライフボンド リミテッド ゼラチン−トランスグルタミナーゼ止血ドレッシング及びシーラント
JP5450612B2 (ja) 2008-06-18 2014-03-26 ライフボンド リミテッド 改良された架橋組成物
AU2009281757A1 (en) 2008-08-15 2010-02-18 Arizona Board Of Regents For And On Behalf Of Arizona State University Porous materials for biological sample collection
WO2011002536A2 (en) 2009-04-08 2011-01-06 Energ2, Inc. Manufacturing methods for the production of carbon materials
US9962468B2 (en) * 2009-04-16 2018-05-08 The University Of Memphis Research Foundation Cell growth apparatus and use of aerogels for directed cell growth
WO2011003033A1 (en) 2009-07-01 2011-01-06 Energ2, Inc. Ultrapure synthetic carbon materials
EP2515957B1 (en) 2009-12-22 2015-07-29 Lifebond Ltd Modification of enzymatic crosslinkers for controlling properties of crosslinked matrices
US8916296B2 (en) 2010-03-12 2014-12-23 Energ2 Technologies, Inc. Mesoporous carbon materials comprising bifunctional catalysts
US8961544B2 (en) 2010-08-05 2015-02-24 Lifebond Ltd. Dry composition wound dressings and adhesives comprising gelatin and transglutaminase in a cross-linked matrix
WO2012045002A1 (en) 2010-09-30 2012-04-05 Energ2 Technologies, Inc. Enhanced packing of energy storage particles
JP6324726B2 (ja) 2010-12-28 2018-05-16 ビーエーエスエフ ソシエタス・ヨーロピアＢａｓｆ Ｓｅ 電気化学特性が向上した炭素材料
US20120262127A1 (en) 2011-04-15 2012-10-18 Energ2 Technologies, Inc. Flow ultracapacitor
CN103947017B (zh) 2011-06-03 2017-11-17 巴斯福股份公司 用于混合能量存储装置中的碳‑铅共混物
WO2013120011A1 (en) 2012-02-09 2013-08-15 Energ2 Technologies, Inc. Preparation of polymeric resins and carbon materials
JP2015513570A (ja) * 2012-02-09 2015-05-14 ジョージア − パシフィック ケミカルズ エルエルシー ポリマ樹脂および炭素材料の調製
US10519434B2 (en) 2012-07-13 2019-12-31 Diomics Corporation Biologic sample collection devices and methods of production and use thereof
JP6505020B2 (ja) * 2012-11-26 2019-04-24 ジョージア − パシフィック ケミカルズ エルエルシー ポリマ樹脂および炭素材料の調製
WO2014143213A1 (en) 2013-03-14 2014-09-18 Energ2 Technologies, Inc. Composite carbon materials comprising lithium alloying electrochemical modifiers
US10195583B2 (en) 2013-11-05 2019-02-05 Group 14 Technologies, Inc. Carbon-based compositions with highly efficient volumetric gas sorption
WO2015137980A1 (en) 2014-03-14 2015-09-17 Energ2 Technologies, Inc. Novel methods for sol-gel polymerization in absence of solvent and creation of tunable carbon structure from same
WO2016025021A1 (en) 2014-08-15 2016-02-18 Diomics Corporation Films for biologic analyte collection and analysis and methods of production and use thereof
US20190097222A1 (en) 2015-08-14 2019-03-28 Energ2 Technologies, Inc. Composites of porous nano-featured silicon materials and carbon materials
CN113224274A (zh) 2015-08-28 2021-08-06 14集团技术公司 具有极其持久的锂嵌入的新型材料及其制造方法
CN105582864B (zh) * 2016-03-03 2018-02-13 福建农林大学 一种植物蛋白气凝胶及其制备方法
WO2017160971A1 (en) * 2016-03-16 2017-09-21 The Regents Of The University Of California Three-dimensional hierarchical porous carbon foams for supercapacitors
EP3593369A4 (en) 2017-03-09 2021-03-03 Group14 Technologies, Inc. DECOMPOSITION OF PRECURSORS CONTAINING SILICON ON POROUS SCAFFOLDING MATERIALS
US11998654B2 (en) 2018-07-12 2024-06-04 Bard Shannon Limited Securing implants and medical devices
CN109337380A (zh) * 2018-09-29 2019-02-15 北京卫星制造厂有限公司 一种纤维增强柔性气凝胶复合材料及其制备方法
US11535521B2 (en) * 2020-02-07 2022-12-27 Lawrence Livermore National Security, Llc Large scale synthesis of resorcinol-formaldehyde aerogel
US11174167B1 (en) 2020-08-18 2021-11-16 Group14 Technologies, Inc. Silicon carbon composites comprising ultra low Z
US11639292B2 (en) 2020-08-18 2023-05-02 Group14 Technologies, Inc. Particulate composite materials
US11335903B2 (en) 2020-08-18 2022-05-17 Group14 Technologies, Inc. Highly efficient manufacturing of silicon-carbon composites materials comprising ultra low z
CN113499471A (zh) * 2021-05-26 2021-10-15 深圳德诚达光电材料有限公司 一种自降解的医疗气凝胶颗粒及制备工艺
WO2023170135A1 (en) 2022-03-08 2023-09-14 Aerogel-It Gmbh Process for producing porous materials
CN114891263B (zh) * 2022-05-17 2023-05-05 浙江大学 一种明胶/普鲁兰多糖改性生物气凝胶

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4041010A (en) * 1975-10-06 1977-08-09 General Electric Company Solvent resistant room temperature vulcanizable silicone rubber compositions
JPS52154856A (en) * 1976-06-18 1977-12-22 Shin Etsu Chem Co Ltd Adherent silicone composition
JPS5641252A (en) * 1979-09-11 1981-04-17 Toshiba Silicone Co Ltd Heat-curable silicone rubber composition
US4529752A (en) * 1982-09-02 1985-07-16 General Electric Company Solvent resistant vulcanizable silicone rubber composition
US4818542A (en) * 1983-11-14 1989-04-04 The University Of Kentucky Research Foundation Porous microspheres for drug delivery and methods for making same
JPH0811783B2 (ja) * 1987-02-19 1996-02-07 ゼネラル・エレクトリック・カンパニイ オルガノポリシロキサン塗装用組成物
US4873218A (en) * 1988-05-26 1989-10-10 The United States Department Of Energy Low density, resorcinol-formaldehyde aerogels
US4929669A (en) * 1988-12-27 1990-05-29 Dow Corning Corporation Organosiloxane compositions yielding elastomers with improved recovery following prolonged compression
GB8928250D0 (en) * 1989-12-14 1990-02-21 Erba Carlo Spa Use of supercritical fluids to obtain porous sponges of biodegradable polymers
JPH0791474B2 (ja) * 1990-09-07 1995-10-04 信越化学工業株式会社 シリコーンゴム組成物及び硬化物
US5081163A (en) * 1991-04-11 1992-01-14 The United States Of America As Represented By The Department Of Energy Melamine-formaldehyde aerogels

Also Published As

Publication number Publication date
EP0707474B1 (en) 2000-08-16
DE69425573D1 (de) 2000-09-21
NO955361D0 (no) 1995-12-29
GB9313501D0 (en) 1993-08-11
EP0707474A1 (en) 1996-04-24
WO1995001165A1 (en) 1995-01-12
DE69425573T2 (de) 2001-05-23
JPH09500114A (ja) 1997-01-07
AU7006794A (en) 1995-01-24

Similar Documents

Publication Publication Date Title
NO955361L (no) Organiske aerogeler
ES2603086T3 (es) Uso de la daptomicina
ES2191192T3 (es) Tienopirimidinas.
ES2149775T3 (es) Composicion para el tratamiento de tejidos que comprende fibrina o fibrinogeno y un polimero biodegradable y biocompatible.
BRPI0412526A (pt) composto, uso de um composto, composição farmacêutica, formulação em aerossol farmacêutica, e, método para o tratamento de um paciente humano ou animal com uma condição anti-inflamatória e/ou alérgica
DE60124285D1 (de) Beschichtete medizinische geräte
AR008878A1 (es) Antagonistas del receptor de vitronectina, un metodo para su preparacion, una composicion farmaceutica que los contiene y el uso de las mismas para la preparacion de un medicamento.
CY1105834T1 (el) Χρηση παρασκευασματων για την εφαρμογη, στον κατω αναπνευστικο σωληνα αντισηπτικων παραγοντων και/ή παραγοντων που προαγουν την επουλωση των πληγων
ID22689A (id) Metode untuk mengaktifkan sel-sel yang menunjukan-sifat antigen manusia, sel-sel teraktifkan yang menunjukan sifat antigen manusia, dan penggunaannya
AR020001A1 (es) COMPUESTOS ACTIVADORES DE hPPARGAMMA Y hPPARALFA, COMPOSICIONES FARMACEUTICAS QUE LOS COMPRENDEN, METODO PARA EL TRATAMIENTO Y/O PREVENCION DE UNAENFERMEDAD MEDIADA POR LOS MISMOS, Y SU USO PARA LA ELABORACION DE UN MEDICAMENTO
AR029175A1 (es) Derivados 2-amino-fenilpurina, un proceso para su preparacion, composicion farmaceutica que los comprende, y el uso de los mismos para la preparacion de un medicamento
AR015940A1 (es) Derivados de rapamicina que contiene tetrazol con vidas medias acortadas y su uso para la manufactura de un medicamento
AR023423A1 (es) Derivados de adamantano, procedimientos para su preparacion, composicion farmaceutica, procedimiento para la preparacion de la composicion farmaceutica, yuso de dichos derivados para la manufactura de medicamentos
BR0009770A (pt) Derivados de bisindóis indigóides capazes de penetrarem na membrana de células, formulação farmacêutica e utilização da mesma
NO20065904L (no) Terapeutiske forbindelser
CY1107838T1 (el) Παραγωγα αδαμαντανιου για τη θεραπεια φλεγμονωδων, ανοσολογικων και καρδιαγγειακων ασθενειων
AR007961A1 (es) Derivados de cicloalquilo como inhibidores de la resorcion osea y antagonistas de receptores de vitronectina, procedimiento para su preparacion y preparado farmaceutico.
ES2092890T3 (es) Aplicacion del riluzol en el tratamiento de la enfermedad de parkinson y de los sindromes de parkinson.
AR020662A1 (es) Compuestos dihidrotiazoles policiclicos, procedimientos para su preparacion, medicamento, procedimiento para la preparacion de dicho medicamento y lautilizacion de dichos compuestos para la preparacion de un medicamento.
CY1105849T1 (el) Χρηση αντισηπτικων στην εμπορικη κατασκευη φαρμακευτικου παρασκευασματος προς αποτροπη ή θepαπεια εναντι φλεγμονων εντος του ανθρωπινου σωματος
AR010700A1 (es) Derivados de purina sustituidos, procedimiento para su preparacion, su empleo y su agente que los contiene
CY1115407T1 (el) Θοριο-227 για χρηση στην ακτινοθεραπεια ασθενειων των μαλακων ιστων
DK0998287T3 (da) Anvendelse af levobupivacain
MD2550C2 (ro) Preparat antibiotic cu eliberare lenta a ingredientului activ şi utilizare a acestuia
DE69718734T2 (de) Bicyclisch-aromatische Verbindungen

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application